Chemokines and HIV infection

Current Opinion in Infectious Diseases

Volumn 10, Issue 1, 1997, Pages 12-17

  Gallo, Robert C ^a   Lusso, Paolo ^b  

^a UNIVERSITY OF MARYLAND   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; GLYCOPROTEIN GP 120; SYNAPSIN I; VIRUS ENVELOPE PROTEIN;

CYTOTOXIC LYMPHOCYTE; GENE DELETION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MACROPHAGE; NONHUMAN; SHORT SURVEY; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 0030975471     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199702000-00004     Document Type: Short Survey

References (35)

1. Lindley IJD, Westwick J, Kunkel SL: Nomenclature announcement-the chemokines. Immunol Today 1993, 14:24.
2. Schall TJ: The chemokines. The cytokine handbook. Edited by Thompson A. New York: Academic Press; 1994:419-460.
3. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Ann Rev Immunol 1994, 55:97-179.
4. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Baza JF, Moore KW, Schall TJ, Zlotnik A: Lymphotactin: a cytokine that represents a new class of chemokines. Science 1994, 266:1395-1399.
5. 8+ T cell-derived HIV-suppressive factor that had remained elusive for almost 10 years.
6. Paul WE: Can the immune response control HIV infection? Cell 1995, 82:177-182.
7. 8+ T lymphocytes can control HIV infection in vitro by suppressing viral replication. Science 1986, 234:1563-1566.
8. Cocchi F, DeVico A, Garzino-Demo A, Cara A, Gallo RC, Lusso P: The V3 domain of HIV-1 envelope glycoprotein gp120 is critical for chemokine-mediated blockade of infection. Nat Med 1996, 2: 1244-1247. This paper sheds light on the mechanism of action of the HIV-suppressive chemokines, pointing to an extracellular blockade of viral entry, dependent on the sequence of the viral V3 loop, but independent of signal transduction through chemokine receptors.
9. Paxton WA, Martin S, Tse D, O'Brien T, Skurnick J, Van Devanter N, Padian N, Braun J, Kotler D, Wolinsky S, Koup R:Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures Nature Med 1996, 2:412-417. The first bridge launched between the observation of the natural resistance to infection in some multiply exposed individuals and the HIV-suppressive chemokines.
10. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Gerard N, Gerard C, Sodroski J: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates Cell 1996, 85:1135-1148. One of the five simultaneous articles which identified CCR5 as the major coreceptor for macrophage-tropic HIV-1 isolates. It also identifies CCR3 as a potential accessory coreceptor.
11. Oravecz T, Pall M, Norcross M: β-chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step. J Immunol 1996, 157:1329-1332. This work helps to elucidate the mechanism of action of the HIV-suppressive chemokines by showing that the virus is blocked at an early stage, most probably during the fusion process.
12. Schmidtmayerova H, Sherry B, Bukrinsky M: Chemokines and HIV replication [Letter]. Nature 1996, 382:767.
13. Verani A, Scarlatti G, Tresoldi E, Colognesi C, Polo S, Lusso P, Siccardi AG, Vercelli D: HIV suppressive activity of C-C chemokines released by LPS-stimulated macrophages. J Exp Med, 1997 (In press). This study elucidates the mechanism of HIV suppression induced by the bacterial endotoxin lipipolysaccharide, conclusively showing an HIV-suppressive effect of chemokines in cells of the mononuclear phagocytic system.
14. Alkhatib G, Combardiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958. One of the five simultaneous articles which identified CCR5 as the major coreceptor for macrophage-tropic HIV-1 isolates.
15. Power CA, Wells TNC: Cloning and characterization of human chemokine receptors. Trends Pharmacol Sci 1996, 17:209-213.
16. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877. Using a novel, powerful technique for functional cDNA library screening, this landmark work identified an 'orphan' chemokine receptor-like protein as the first HIV co-receptor, specific for T cell line-adapted viral strains, paving the way for the subsequent discovery of the other HIV co-receptors.
17. Horuk R, Chitnis CE, Darbonne WC, Colby TJ, Rybicki A, Hadley TJ, Miller LH: A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993, 261:1182-1184.
18. Deng H, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton R, Hill M et al.: Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996, 381:661-666. One of the five simultaneous articles which identified CCR5 as the major coreceptor for macrophage-tropic HIV-1 isolates.
19. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-678. One of the five simultaneous articles which identified CCR5 as the major coreceptor for macrophage-tropic HIV-1 isolates.
20. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Nature 1996, 85:1149-1158. One of the five simultaneous articles which identified CCR5 as the major coreceptor for macrophage-tropic HIV-1 isolates. It also points to CCR2b and CCR3 as potential accessory coreceptors.
21. Samson M, Labbe O, Mollerau C, Vassart G, Parmentier M: Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996, 35:3362-3367.
22. Loetscher P, Seitz M, Baggiolini M, Moser B: Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996, 184:569-577. This study suggests an intriguing mechanism whereby specific signalling pathways may regulate chemokine-receptor expression and thus the susceptibility of T lymphocytes to HIV-1 infection.
23. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996, 382:829-832. One of the two papers which identified a natural ligand for the previously 'orphan' receptor LESTR/fusin, thence designated CXCR4.
24. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF et al.: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996, 382:833-835. One of the two papers which identified a natural ligand for the previously 'orphan' receptor LESTR/fusin, thence designated CXCR4.
25. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA: A highly efficacious lymphocyte chemoattractant stromal cell-derived factor 1 (SDF-1). J Exp Med 1996, 184:1101-1109.
26. + hemotopoietic progenitor cells and provides a new mechanism to explain their mobilization to peripheral blood. J Exp Med 1997, (In press).
27. Nagasawa T, Hirota S, Tachibana K, Takakuras N, Nishikawas S, Kitamura Y, Yoshida, Kikutani H, Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
28. Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O: Requirement of MIP-1α for an inflammatory response to viral infection. Science 1995, 269:1583-1585. Using mice with deleted MIP-1α genes, documents the important and double-sided role of this chemokine in the inflammatory responses that accompany viral infection.
29. Schmidtmayerova H, Nottet HSLM, Nuovo G, Raabe T, Flanagan C, Dubrovsky L, Gendelman HE, Cerami A, Bukrinsky M, Sherry B: Human immunodeficiency virus type 1 infection alters chemokine βpeptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymphonodes Proc Natl Acad Sci USA 1996, 93:700-704.
30. Tedla N, Palladinetti P, Kelly M, Kumar RK, Digirolamo N, Chattophadhay U, Cooke B, Truskett P, Dwyer J, Wakefield D, Lloyd A: Chemokines and T lymphocyte recruitment to lymph nodes in HIV infection. Am J Patho 1996, 148:1367-1373.
31. + T-lymphocytes from two multiply exposed uninfected Individuals resist infection with primary NSI isolates of human immunodeficiency virus-type 1. J Virol 1996, 70:8758-8764.
32. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber C-M, Saragosti S, Lapoumerouilie C, Cognaux J, Forceille C et al: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996, 382:722-725. One of the two papers identifying a homozygous 32-bp deletion in the CCR5 gene as the mechanism of protection from HIV infection in a small proportion of Caucasian individuals. The first conclusive evidence of a genetic determinant of susceptibility to HIV infection.
33. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlman H, Koup RA, Landau NR: Homozygous defect in HIV-1 co-receptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996, 86:1-11. One of the two papers identifying a homozygous 32-bp deletion in the CCR5 gene as the mechanism of protection from HIV infection in a small proportion of Caucasian individuals. The first conclusive evidence of a genetic determinant of susceptibility to HIV infection.
34. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittinghoff E, Gomperts E et al. and the Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study: Genetic restriction of HIV-1 infection and progression by a deletion allele of the CKR5 structural gene. Science 1996, 273:1856-1861. A large multi-cohort study that expanded the previous two studies. It also suggests an association between heterozygosity for the CCR5 defect and slow progression of HIV disease.
35. + T cells.